HomeTRDA • NASDAQ
add
Entrada Therapeutics Inc
Previous close
$8.12
Day range
$7.99 - $8.19
Year range
$7.10 - $21.79
Market cap
307.04M USD
Avg Volume
161.47K
P/E ratio
10.01
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 20.56M | -65.23% |
Operating expense | 10.27M | 9.31% |
Net income | -17.35M | -173.84% |
Net profit margin | -84.39 | -312.36% |
Earnings per share | -0.42 | -161.76% |
EBITDA | -20.84M | -194.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 382.52M | 16.83% |
Total assets | 486.48M | -4.77% |
Total liabilities | 69.22M | -71.34% |
Total equity | 417.26M | — |
Shares outstanding | 35.26M | — |
Price to book | 0.69 | — |
Return on assets | -10.76% | — |
Return on capital | -11.32% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -17.35M | -173.84% |
Cash from operations | -38.51M | -50.90% |
Cash from investing | 4.78M | -81.71% |
Cash from financing | 350.00K | 69.90% |
Net change in cash | -33.37M | -4,101.68% |
Free cash flow | -29.37M | 21.01% |
About
Founded
2016
Headquarters
Website
Employees
183
